Cefuroxime is the sodium salt of (6R, 7R)-3carbamoyloxy-methyl-7-(2Z)-2-methoxyimino (fur-2-yl) acetamido-ceph-3-em-4-carboxylic acid. It is a new semi-synthetic cephalosporin characterized by its stability to numerous fl-lactamases, which would make it particularly useful for the treatment of infections due to Escherichia coli, indole positive Proteus spp., Klebsiella spp., Pro videncia and Haemophilus influenza.
The first pharmacokinetic studies were published by O'Callaghan et al. (1976 ) Foord (1976 and Goodwin et al. (1977) . The purpose of the present study was to compare the serum and urinary levels, as well as the pharmacokinetic data obtained after i.v. or i.m. injection of single 500 mg doses to healthy subjects. This work was completed by a study of the passage of cefuroxime into the bile in cholecystectomized patients with T-tube drainage.
MATERIALS AND METHODS

Selection ofPatients
The serum and urinary concentrations of cefuroxime were measured in 20 healthy subjects without hepatic or renal impairment. In 10 cases (blood urea nitrogen, BUN, <40 mg/100 ml and creatinine clearance, Ccr, <90 ml/min), the drug was administered i.v. as a single 500 mg dose. In the remaining 10 cases (BUN <30 mg/100 ml and Ccr <105 ml/min) the same dose was given by i.m. injection. In 10 cholecystectomized patients who required T-tube drainage, the biliary concentrations of cefuroxime were measured on the seventh post-operative day, i.e. some time after the operation but at a time when the quantities of bile channelled through the drain were still important.
Experimental Procedure
In the healthy volunteers who received cefuroxime i.v. or i.m. blood samples were taken before, as well as 5, 15, 30, 60, 90 min and 2, 3, 4, 6 and 8 h after the injection. Urine was collected during the first 6 h following the injection. In patients with T-tube drainage, blood and bile samples were collected hourly during the 12 h following an i.v. injection of 500 mg.
Cefuroxime Assay
The concentrations of cefuroxime in serum, bile and urine were measured by the method of dilution on gelose plates in contact with metal cylinders. Bacillus subtilis (1904 E) was used as test-organism. The standard curves were established in foetal calf serum for blood levels and in phosphate buffer solution (pH 6.0, 0.1 M) for concentrations in bile and urine.
Pharmacokinetic Analysis
The sequence of serum concentrations was analysed with the help of a computer programmed to calculate the regression curves by the method of least squares.
Following i.v. injection, the kinetics of the curve were suggestive of an open two-compartment model (C=Aoe-at+Boe-t). The distribution phase (A=Aoe-at) and the elimination phase (B=Boe-Ot) were distinguished by the feathering method. From the constants so obtained, the elimination constant Kei and the distribution constants K1.2 and K2.1 were determined: Co a.f3
The biological half-life (Tb,B0 of cefuroxime was given by the formula: Tbi=0and the apparent volume of distribution by the equations: AVC (central apparent volume of distribution) The sequence of serum concentrations obtained after i.m. injection of cefuroxime was analysed by reference to Bateman's function: C =Bo Ka-f (e-0-e Kat), where Ka is the resorption constant corresponding to the slope of the resorption curve calculated by the so-called 'residual values' method. The lag time in these conditions correspond to: log n (Ao/Bo) logBn g(K(a-) )and t max to:
Once t max is known, it is easy to calculate Cmax.
In the patients with T-tube drainage, the biliary clearance Cb corresponds to the ratio mb/AUC (where mb=quantity of cefuroxime excreted in the bile), and the coefficient of biliary excretion Kb to the ratio Cb/AVC.
RESULTS
Intravenous Administration ofCefuroxime to Healthy Subjects After i.v. injection of 500 mg of cefuroxime, the mean serum levels were 57.0±8.4,ug/ml at 5 min, falling to 19.5±2.5 ,ug/ml at 30 min and 9.1 ±1.4 ,ug/ml at I h. After 3 h the level in the serum had decreased to 2.0 ±0.3 ug/ml while at 6 h it was 0.4 ,g/ml. Concentrations were barely measurable (0.2,ug/ml) at 9 h (Fig 1) .
The equation of the curve established from these serum concentration values was C=53.3 e-3.0809c + 11.3 e-O0 433t. The initial theoretical serum concentration (Co) was 64.6 jig/ml (Co =Ao+Bo). The Ao and a constants, which characterize the initial distribution phase, were 53.3 ,ug/ml and 3.0809/h respectively. The Bo and fi constants, which apply to the terminal or elimination phase, were 11.3 ,ug/ml and 0.5433/h respectively (Figs 2 and 3 
Intramuscular Administration of Cefuroxime to Healthy Subjects
After i.m. injection of a 500 mg dose of cefuroxime, the following mean serum concentrations were obtained ( Fig 5) 5.3 ± 1.0 ,tg/ml at 5 min, 13.5±1.8,ug/ml at 15 min, 21.8±2.8 jg/ml at 30 min, and 18.9±3.0 ,ug/ml at 60 min. The 4 h figures were 2.8 ±0.8 ,tg/ml and at 6 h the level had fallen to 0.8 ±0.3 ,tg/ml. The breakdown of the curve into an absorption phase and an excretion phase ( Fig 6) made it possible to determine the following constants:
Ka=4.7936/h Ke=0.6021/h Taj and Tfi =0.15 and 1.15 h respectively The initial theoretical concentration Bo was 33.7,ug/ml. It was possible to calculate a lag time to of 0.04 h. The theoretical maximum concentration, Cmax (=25.0 ,ug/ml) was reached after 0.50 h (=t max).
The area under the curve of serum concentrations, AUCOGoo, was found to be 47.8 h ,g/ml. Predicted serum concentrations were calculated for r values (-r =dosage interval) of 2, 3, 4 and 6 h. The determinations were effected by assimilating the decrease in concentrations to a monoexponential curve, the elimination rate-constant Ke then being calculated for the corresponding periods of 2, 3, 4 or 6 h (Table 1) .
From the MIC values given in the literature (Goodwin et al. 1977 , Meunier-Carpentier & Klastersky 1977 , Norrby et al. 1976 , O'Callaghan et al. 1976 , Ryan et al. 1976 ) it would appear that a 500 mg i.m. injection of cefuroxime every 2 h would permanently inhibit the growth of all sensitive organisms, including Bacteroidesfragilis. Most strains of Enterobacter and Klebsiella would still be inhibited by 3 hourly injection and most strains of methicillin-resistant Staphylococcus aureus, E. coli, Proteus mirabilis and Salmonella spp., by 4 hourly injections. A 500 mg injection every 6 h would give serum concentrations consistently higher than the MICs of methicillin sensitive strains of Staphylococcus aureus, Neisseria meningitidis and ampicillinsensitive or resistant Hamophilus influenza.
To obtain serum concentration immediately equivalent to the values observed during the steady-state, it is necessary to give a loading dose, LD, calculated from the equation:
LD=D I I e-Ker
(where D =normal dose). According to whether r is 2, 3, 4 or 6 h, this loading dose would be 536 mg, 526 mg, S1S mg or 507 mg respectively (Table 1) .
The theoretical maximum and minimum serum concentrations of cefuroxime after repeated i.m. injections were calculated from the following equations:
I-e-nKe'r The values thus obtained for r intervals of 2, 3, 4 and 6 h together with the loading dose (LD) calculated for each case, are given in Table 2 . The biliary concentrations of cefuroxime rise during the 4 h following an injection and thereafter rapidly decrease. The mean bile levels of the drug measured during these first 4 h are equal to, or higher than the MICs of most sensitive pathogens, with the exception of Bacteroides fragilis, some strains of Enterobacter spp. and some strains of Klebsiella spp. These data would justify the use of cefuroxime in the treatment of biliary infections, provided the injections (500 mg i.v.) are administered 3 hourly or 4 hourly, or higher doses are given.
In order to define more accurately the place occupied by cefuroxime among the cephalosporins, its characteristics are compared in Table  3 with those of 7 other derivatives of the same group. The difference observed between its total and renal clearance (75%) suggests that it is to some extent metabolized or electively retained by certain tissues. Its apparent volume of distribution (17.8 litres, or 29% of the body weight) corresponds approximately to that of the extracellular fluid.
Compared with other beta-lactams, previously studied in this laboratory, the biliary excretion of cefuroxime is equal to that of penicillin G, ampicillin, cephaloridine and cefazolin, superior to that of cephalothin and cephacetrile, but inferior to that of metampicillin, cefalexin and carbenicillin (Fig 8) 0.0008 assistance. They also wish to express their gratitude to Dr G Roux for English translation of the manuscript and to Mlle R Leninger for her secretarial work.
Summary
After i.v. injection of 500 mg of cefuroxime to 10 healthy subjects, the fall in serum concentrations was suggestive of a bi-exponential kinetic model. The initial theoretical serum level was 64.6 ,tg/ml and the biological half-life 1.28 h.
Cefuroxime was distributed in a total apparent volume of 15.1 litres. The total clearance was 230 ml/min, and the renal clearance, 172 ml/min. The urinary excretion during the 6 h following the injection amounted to 73 % of the dose administered. After i.m. injection of the same dose to 10 healthy subjects, the mean peak serum level was 21.8 pg/ml (at 0.5 h). The absorption half life was estimated at 0.5 h, and the biological half life at 1.1 5 h. The urinary bioavailability was 100 %.
In 10 cholecystectomized patients with T-tube drainage, the mean biliary excretion ofcefuroxime after a single 500 mg i.v. dose amounted to 0.13 % of the administered dose. The maximum biliary concentration (10.8 ,g/ml) was obtained between the first and the second hour. The biliary clearance was 0.0008/h.
A preliminary study of the serum concentrations during repeated injections was carried out using the pharmacokinetic data previously established. The pharmacokinetic profile of cefuroxime was compared with that of a number of other cephalosporin derivatives. 
DISCUSSION
Professor W Brumfift (London) said that the biliary excretion of drugs, with its surge pattern, bore no relation to urinary excretion, with its more constant pattern. He was interested to see from Professor Brogard's data that there was a delay of 30-60 min in the appearance of drug in the bile in relation to the peak serum level. In collaboration with Professor Sherlock in London ihey had intubated the bile ducts using normal controls, and had also investigated material taken at operation where there was abnormality and the 2 sets of data did not correspond. He felt that one could not relate the results from an abnormal biliary system to what happens in the normal individual. This could only be done by the ERCP technique.
Professor Brogard said that evaluation of the elimination coefficient was not related to peak concentration but only to total antibiotic recovery in the bile.
Dr Kosmidis said that his concern was with the diseased gall-bladder. The aim was to establish whether the drug entered the gall-bladder in the presence of infection or other disease because these were the patients who would receive it. As to kinetics, he agreed that the situation was complex. One must cannulate the common bile duct otherwise with the T-tube one could not know how much entered or left. But these studies gave some idea of the concentrations achieved in normal gall-bladders because they were a reflection of the amount of drug that came via the bile from the liver itself.
Professor E Brumfitt (London) disagreed. The ERCP technique with cannulation of the common bile duct gave different results with the normal gall-bladder than those obtained with the T-tube. Dr Kosmidis conceded that this was correct, but reiterated that it'was the diseased rather than the normal individual that he was concerned with.
Dr P Ball (Birmingham) presented data from one chronically obstructed gall-bladder patient with septicwmia caused by Proteus morganii and Enterobacter cloacam. With a dose of 750 mg i.m. there was a reasonably high serum level, a very high portal venous level, but in the obstructed bile duct, a bile level of only 6 mg/litre. However, a second dosage following surgery took the biliary level up to 20 mg/litre. Whether this was a lag phenomenon or a function of excretion into the non-obstructed duct he did not know. He emphasized the importance of investigating what was happening in the diseased state.
Dr Kosmidis said that after the first injection in his patients, comparable levels of 2-8 mg/litre were obtained. Only after repeated dosages did they go higher. Dr L 0 Gentry (Chairman) assumed that removing the obstruction obviously exerted an influence on the bile level.
Professor G K Daikos (Athens) agreed with Professor Brumfitt that their pharmacokinetic analysis was crude, but their experience in treating cholangitis had been very favourable. They had recorded 5 cases including an Escherichia coli and another Klebsiella in which a dose of 3 g/day had worked effectively.
Dr E Rubinstein (Tel-Hashomer) said that bile itself was somewhat antagonistic to microorganisms and with some cephalosporins its presence increased their MICs perhaps 20-40 fold.
He wondered if bile acted synergistically, antaat SAGE Publications on June 21, 2016 jrs.sagepub.com Downloaded from gonistically or did not change the activity of cefuroxime.
Dr L 0 Gentry (Chairman) said that there was evidence to suggest that bile did act synergistically with cephamandole. Originally it was thought that the drug was concentrated in bile, but it now appeared that there might be some synergism in its anti-bacterial action.
Professor W Brumfitt (London) said that they believed that bile might have an effect on an antibiotic and they invariably tested the antibiotic wherever possible in the presence of the patient's bile.
Professor Modai (Paris) returned to the question of meningitis. He did not believe that meningitis could be treated with a ,-lactam antibiotic alone, but studies of the passage of the antibiotic into the CSF were of value.
Dr Kosmidis doubted whether cefuroxime was a good drug for the treatment of meningitis but if there were no other choice, perhaps with a pencillin-allergic patient, he would give the highest permissible dose into the intrathecal space, perhaps combined with some other agent.
Dr J A Kuzemko (Peterborough) said that the drug entered the inflamed CSF rather well and it was unfair to say that it should not be used because in the 2 cases reported, the Hamophilus influenza, was resistant to all available antibiotics.
